Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank33
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-59.03M
↓ 28% vs avg
Percentile
P33
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-46.17M
Historical baseline
PeriodValueYoY Change
TTM$-59.03M+16.6%
2025$-70.78M+32.3%
2024$-104.51M+15.4%
2023$-123.48M-3.6%
2022$-119.22M-14.4%
2021$-104.25M-174.4%
2020$-37.99M-195.0%
2019$40.00M-56.0%
2018$90.85M+239.6%
2017$26.75M-